title: Exploiting the homologous recombination DNA repair network for targeted cancer therapy.
abstract: Genomic instability is a characteristic of cancer cells. In order to maintain genomic integrity, cells have evolved a complex DNA repair system to detect, signal and repair a diversity of DNA lesions. Homologous recombination (HR)-mediated DNA repair represents an error-free repair mechanism to maintain genomic integrity and ensure high-fidelity transmission of genetic information. Deficiencies in HR repair are of tremendous importance in the etiology of human cancers and at the same time offer great opportunities for designing targeted therapeutic strategies. The increase in the number of proteins identified as being involved in HR repair has dramatically shifted our concept of the proteins involved in this process: traditionally viewed as existing in a linear and simple pathway, today they are viewed as existing in a dynamic and interconnected network. Moreover, exploration of the targets within this network that can be modulated by small molecule drugs has led to the discovery of many effective kinase inhibitors, such as ATM, ATR, DNA-PK, CHK1, and CHK2 inhibitors. In preclinical studies, these inhibitors have been shown to sensitize cancer cells to chemotherapy and radiation therapy. The most exciting discovery in the field of HR repair is the identification of the synthetic lethality relationship between poly (ADP-ribose) polymerase (PARP) inhibitors and HR deficiency. The promises of clinical applications of PARP inhibitors and the concept of synthetic lethality also bring challenges into focus. Future research directions in the area of HR repair include determining how to identify the patients most likely to benefit from PARP inhibitors and developing strategies to overcome resistance to PARP inhibitors.
authors: Guang Peng, Shiaw-Yih Lin, Department of Systems Biology, Unit 950, The University of Texas MD Anderson Cancer Center, South Campus Research Building II, 7435 Fannin, Houston, TX 77054, United States.
authors: Guang
authors: G
authors: Peng
authors: Shiaw-Yih
authors: SY
authors: Lin
references: Mutat Res. 2003 Nov 27;532(1-2):103-15
references: 14643432
references: EMBO J. 2008 May 7;27(9):1368-77
references: 18388863
references: J Clin Oncol. 2008 Aug 1;26(22):3785-90
references: 18591545
references: N Engl J Med. 2009 Jul 9;361(2):123-34
references: 19553641
references: J Biol Chem. 2010 May 7;285(19):14565-71
references: 20233726
references: Front Biosci. 2008 May 01;13:5016-29
references: 18508566
references: Nature. 2005 Apr 14;434(7035):913-7
references: 15829966
references: Epigenetics. 2009 Oct 1;4(7):457-61
references: 19829069
references: Oncogene. 2007 Dec 10;26(56):7816-24
references: 18066095
references: Nat Rev Cancer. 2008 Mar;8(3):193-204
references: 18256616
references: Cell Cycle. 2009 Jun 15;8(12):1872-6
references: 19440052
references: Nature. 2008 Feb 28;451(7182):1111-5
references: 18264088
references: DNA Repair (Amst). 2008 Dec 1;7(12):2010-9
references: 18832051
references: Int J Cancer. 2003 Jul 1;105(4):472-9
references: 12712436
references: PLoS Biol. 2010 Jun 29;8(6):e1000408
references: 20613862
references: Nat Rev Mol Cell Biol. 2010 Mar;11(3):196-207
references: 20177395
references: Cell Res. 2008 Jan;18(1):8-16
references: 18087291
references: N Engl J Med. 2009 Jul 9;361(2):189-91
references: 19553640
references: Nat Genet. 2001 Mar;27(3):247-54
references: 11242102
references: Nat Med. 2003 May;9(5):568-74
references: 12692539
references: Cancer Res. 2006 Aug 15;66(16):8109-15
references: 16912188
references: Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8
references: 20177397
references: J Clin Invest. 2007 May;117(5):1440-9
references: 17431503
references: Nature. 2005 Apr 14;434(7035):917-21
references: 15829967
references: Cancer Res. 2008 Apr 15;68(8):2581-6
references: 18413725
references: Carcinogenesis. 2010 Jun;31(6):955-60
references: 20351092
references: Nature. 2001 May 17;411(6835):366-74
references: 11357144
references: Lung Cancer. 2003 May;40(2):157-64
references: 12711116
references: Nature. 2008 Feb 28;451(7182):1116-20
references: 18264087
references: Curr Opin Genet Dev. 2008 Feb;18(1):80-6
references: 18343102
references: Nat Struct Mol Biol. 2010 Jun;17(6):688-95
references: 20453858
references: Cancer Cell. 2010 Mar 16;17(3):235-48
references: 20227038
references: Cell. 2010 Apr 16;141(2):243-54
references: 20362325